The study participants had the following prevalence of risk factors for osteoporosis: 9.6% of the participants were taking glucocorticoids, 2.4% were underweight, 0.6% of the participating women were taking aromatase inhibitors, and 0.5% had major osteoporotic fractures. This evidence concerns the gene CYP19A1 and osteoporosis.